E
Enrique C. Jolly
Researcher at University of Buenos Aires
Publications - 11
Citations - 1127
Enrique C. Jolly is an academic researcher from University of Buenos Aires. The author has contributed to research in topics: FEV1/FVC ratio & Community-acquired pneumonia. The author has an hindex of 6, co-authored 11 publications receiving 1111 citations.
Papers
More filters
Journal ArticleDOI
Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia
Carlos M. Luna,Patricia Vujacich,Michael S. Niederman,Carlos Vay,Carlos R Gherardi,Josue Matera,Enrique C. Jolly +6 more
TL;DR: The impact of BAL data on the selection of antibiotics and the outcomes of patients with ventilator-associated pneumonia (VAP) is defined and mortality rate is reduced if this empiric therapy is adequate, compared to when this therapy is inadequate or no therapy is given.
Journal ArticleDOI
Effects of Supplemental Oxygen During Activity in Patients With Advanced COPD Without Severe Resting Hypoxemia
Enrique C. Jolly,Valentina Di Boscio,Laura Aguirre,Carlos M. Luna,Sara Berensztein,Ricardo J. Gene +5 more
TL;DR: Most of the studied COPD patients desaturated during the BWT, and the therapeutic role of O(2) during activities in some patients with severe COPD needs to be individually assessed.
Journal ArticleDOI
Pulmonary lymphangiomyomatosis associated with tuberous sclerosis. Treatment with tamoxifen and tetracycline-pleurodesis.
Carlos M. Luna,Ricardo J. Gene,Enrique C. Jolly,Nelly Nahmod,Hector Defranchi,Guillermo Patino,Boris Eisner +6 more
TL;DR: The discovery in this case of an estrogen receptor represents important evidence for establishing an association between tuberous sclerosis and lymphangiomyomatosis.
Journal ArticleDOI
Effect of Tracheal Dilatation and Rupture on Mechanical Ventilation Using a Low-Pressure Cuff Tube
TL;DR: A 36-year-old woman who suffered tracheal dilatation and rupture despite careful monitoring of intracuff pressure is reported, suggesting surgical manipulation, postoperative mediastinitis, and bacterial staphylococcal tracheitis may be involved.
Journal Article
Acute effect of lorazepam on respiratory muscles in stable patients with chronic obstructive pulmonary disease
TL;DR: It is demonstrated that a single lorazepam dose reduces strength and endurance of respiratory muscle in chronic stable COPD patients.